Relaxin regulates vascular wall remodeling and passive mechanical properties in mice

Journal of Applied Physiology

Volumn 111, Issue 1, 2011, Pages 260-271

  Debrah, Dan O ^a   Debrah, Julianna E ^b   Haney, Jamie L ^a   Mcguane, Jonathan T ^c   Sacks, Michael S ^a,d   Conrad, Kirk P ^c   Shroff, Sanjeev G ^a,d  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Arterial collagen; Arterial compliance; Elastin; Matrix metalloproteinase 2; Relaxin knockout mice; Smooth muscle

Indexed keywords

COLLAGEN; ELASTIN; GELATINASE; RECOMBINANT PROTEIN; RELAXIN;

ANIMAL; ARTICLE; BIOMECHANICS; BLOOD PRESSURE; C57BL MOUSE; COMPLIANCE (PHYSICAL); FEMALE; GENETICS; HUMAN; ILIAC ARTERY; MECHANICAL STRESS; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; RENAL ARTERY; TIME;

ANIMALS; BIOMECHANICS; BLOOD PRESSURE; COLLAGEN; COMPLIANCE; ELASTIN; FEMALE; GELATINASES; HUMANS; ILIAC ARTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; RELAXIN; RENAL ARTERY; STRESS, MECHANICAL; TIME FACTORS;

EID: 79960210810     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00845.2010     Document Type: Article

References (52)

1. Armentano RL, Levenson J, Barra JG, Fischer EI, Breitbart GJ, Pichel RH, Simon A. Assessment of elastin and collagen contribution to aortic elasticity in conscious dogs. Am J Physiol Heart Circ Physiol 260:H1870-H1877, 1991.
2. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JG. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 89:180-186, 2001. (Pubitemid 34135827)
3. Cipolla M, Osol G. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall. Am J Obstet Gynecol 171:805-811, 1994. (Pubitemid 24312368)
4. Conrad KP. Renal hemodynamics during pregnancy in chronically catheterized, conscious rats. Kidney Int 26:24-29, 1984. (Pubitemid 14060584)
5. Conrad KP. Unveiling the vasodilatory actions and mechanisms of relaxin. Hypertension 56:2-9, 2010.
6. Conrad KP, Debrah DO, Novak J, Danielson LA, Shroff SG. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. Endocrinology 145:3289-3296, 2004. (Pubitemid 38830001)
7. Conrad KP, Novak J. Emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 287:R250-R261, 2004. (Pubitemid 38970272)
8. Cox RH. Passive mechanics and connective tissue composition of canine arteries. Am J Physiol Heart Circ Physiol 234:H533-H541, 1978. (Pubitemid 9158736)
9. Danielson LA, McGuane JT, Debrah JE, Conrad KP. Relaxin-induced renal vasodilation and hyperfiltration are mediated by vascular endothelial growth factor receptor (s) in chronically-instrumented, conscious rats (Abstract). Reprod Sci 11:357A, 2010.
10. Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 103:525-533, 1999. (Pubitemid 29094053)
11. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 75:519-560, 1995.
12. De Mey JG, Schiffers PM, Hilgers RH, Sanders MM. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol 288:H1022-H1027, 2005. (Pubitemid 40270002)
13. Debrah DO, Conrad KP, Danielson LA, Shroff SG. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response. J Appl Physiol 98:1013-1020, 2005. (Pubitemid 40283683)
14. Debrah DO, Conrad KP, Jeyabalan A, Danielson LA, Shroff SG. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats. Hypertension 46:745-750, 2005. (Pubitemid 43186748)
15. Demiray H, Weizsacker HW, Pascale K. A mechanical model for passive behaviour of rats' carotid artery. Biomed Tech (Berl) 31:46-52, 1986. (Pubitemid 16139113)
16. Dobrin PB, Canfield TR. Elastase, collagenase, and the biaxial elastic properties of dog carotid artery. Am J Physiol Heart Circ Physiol 247:H124-H131, 1984. (Pubitemid 14092205)
17. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Tregear GW. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57:395-404, 2003. (Pubitemid 36144218)
18. Fisher C, MacLean M, Morecroft I, Seed A, Johnston F, Hillier C, McMurray J. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation 106:292-295, 2002. (Pubitemid 34778949)
19. Fung YC, Fronek K, Patitucci P. Pseudoelasticity of arteries and the choice of its mathematical expression. Am J Physiol Heart Circ Physiol 237:H620-H631, 1979. (Pubitemid 10194629)
20. Gandley RE, Conrad KP, McLaughlin MK. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regul Integr Comp Physiol 280:R1-R7, 2001.
21. Garber SL, Mirochnik Y, Brecklin CS, Unemori EN, Singh AK, Slobodskoy L, Grove BH, Arruda JA, Dunea G. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 59:876-882, 2001. (Pubitemid 32206850)
22. Hammer ES, Cipolla MJ. Arterial wall hyperplasia is increased in placental compared with myoendometrial radial uterine arteries from late-pregnant rats. Am J Obstet Gynecol 192:302-308, 2005. (Pubitemid 40164257)
23. Humphrey JD. Cardiovascular Solid Mechanics: Cells, Tissues, and Organs. New York: Springer-Verlag New York, 2002.
24. Jeyabalan A, Conrad KP. Renal physiology and pathophysiology in pregnancy. In: Renal and Electrolyte Disorders, edited by Schrier RWE. Philadelphia, PA: Lippincott Williams & Wilkins, 2010, p. 462-518.
25. Jeyabalan A, Kerchner LJ, Fisher MC, McGuane JT, Doty KD, Conrad KP. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J Appl Physiol 100:1955-1963, 2006. (Pubitemid 43845871)
26. Jeyabalan A, Novak J, Danielson LA, Kerchner LJ, Opett SL, Conrad KP. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res 93:1249-1257, 2003. (Pubitemid 37543066)
27. Jeyabalan A, Novak J, Doty KD, Matthews J, Fisher MC, Kerchner LJ, Conrad KP. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin. Endocrinology 148:189-197, 2007. (Pubitemid 46023450)
28. Jeyabalan A, Shroff SG, Novak J, Conrad KP. The vascular actions of relaxin. Adv Exp Med Biol 612:65-87, 2007.
29. Kuzuya M, Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 10:275-282, 2003.
30. McGuane JT, Debrah JE, Sautina L, Rubin JP, Novak J, Segal MS, Conrad KP. Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide. Endocrinology 2011 May 10. [Epub ahead of print].
31. McGuane JT, Danielson LA, Debrah JE, Rubin JP, Novak J, Conrad KP. Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans. Hypertension 57:1151-1160, 2011.
32. McGuane JT, Parry LJ. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease. Expert Rev Mol Med 7:1-18, 2005.
33. Novak J, Parry LJ, Matthews JE, Kerchner LJ, Indovina K, Hanley-Yanez K, Doty KD, Debrah DO, Shroff SG, Conrad KP. Evidence for local relaxin ligand-receptor expression and function in arteries. FASEB J 20:2352-2362, 2006. (Pubitemid 44953865)
34. Novak J, Ramirez RJ, Gandley RE, Sherwood OD, Conrad KP. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol Regul Integr Comp Physiol 283:R349-R355, 2002. (Pubitemid 34863882)
35. Osol G, Cipolla M. Pregnancy-induced changes in the three-dimensional mechanical properties of pressurized rat uteroplacental (radial) arteries. Am J Obstet Gynecol 168:268-274, 1993. (Pubitemid 23047651)
36. Samuel CS. Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res 3:241-249, 2005.
37. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, Tregear GW, Du XJ. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145:4125-4133, 2004. (Pubitemid 39120561)
38. Samuel CS, Zhao C, Bathgate RA, Bond CP, Burton MD, Parry LJ, Summers RJ, Tang ML, Amento EP, Tregear GW. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17:121-123, 2003.
39. Samuel CS, Zhao C, Bond CP, Hewitson TD, Amento EP, Summers RJ. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int 65:2054-2064, 2004. (Pubitemid 38669991)
40. Samuel CS, Zhao C, Yang Q, Wang H, Tian H, Tregear GW, Amento EP. The relaxin gene knockout mouse: a model of progressive scleroderma. J Invest Dermatol 125:692-699, 2005.
41. Schulze-Bauer CA, Morth C, Holzapfel GA. Passive biaxial mechanical response of aged human iliac arteries. J Biomech Eng 125:395-406, 2003. (Pubitemid 36876434)
42. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 25:205-234, 2004. (Pubitemid 38501394)
43. Smith MC, Danielson LA, Conrad KP, Davison JM. Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers. J Am Soc Nephrol 17:3192-3197, 2006. (Pubitemid 44707780)
44. Tozzi CA, Poiani GJ, McHugh NA, Shakarjian MP, Grove BH, Samuel CS, Unemori EN, Riley DJ. Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat. Pulm Pharmacol Ther 18:346-353, 2005. (Pubitemid 40804532)
45. Tulis DA, Unthank JL, Prewitt RL. Flow-induced arterial remodeling in rat mesenteric vasculature. Am J Physiol Heart Circ Physiol 274:H874-H882, 1998.
46. Tuttle JLNR, Bhuller AS, Condict KW, Connors BA, Herring BP, Dalsing MC, Unthank JL. Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 281:H1380-H1389, 2001.
47. Unemori EN, Amento EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265:10681-10685, 1990.
48. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, Amento EP. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98:2739-2745, 1996. (Pubitemid 26427400)
49. Vaishnav RN, Young JT, Janicki JS, Patel DJ. Nonlinear anisotropic elastic properties of the canine aorta. Biophys J 12:1008-1027, 1972.
50. van Eijndhoven HW, Janssen GM, Aardenburg R, Spaanderman ME, Peeters LL, De Mey JG. Mechanisms leading to increased vasodilator responses to calcitonin-gene-related peptide in mesenteric resistance arteries of early pregnant rats. J Vasc Res 45:350-356, 2008. (Pubitemid 351793738)
51. Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN, Iredale JP. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 49:577-583, 2001. (Pubitemid 32896990)
52. Xu Q, Chakravorty A, Bathgate RA, Dart AM, Du XJ. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension 55:1260-1266, 2010.